Is There Really a Pill That Helps a Dog Live Longer?

Is there a pill that helps a dog live longer? I get asked this more than almost anything else in exam room conversations with owners of graying dogs, and I understand why — nobody wants to watch a ten-year-old lab go from running the yard to hesitating at the porch step. But the honest answer up front: no supplement has clinical trial data showing dogs that took it lived measurably longer than dogs that didn’t. What does exist is a smaller, more useful claim — a handful of ingredients with biological plausibility and early evidence for supporting cellular aging processes. That’s a real thing. It’s just not the thing the marketing implies.

I want to be direct about why that distinction matters, because I’ve watched it play out in my own exam room. A twelve-year-old beagle named Ruth came in with her owner clutching a bag of chews she’d found on Instagram, convinced they’d add years to Ruth’s life. Ruth was thin, her stairs had become a two-attempt project, and her owner had already spent close to two hundred dollars a month on three different “longevity” products stacked together. We talked for twenty minutes about what each ingredient actually does versus what the label implied. She left with one product instead of three, a lower bill, and — more importantly — a bloodwork panel scheduled to catch the arthritis and early kidney changes that were driving Ruth’s actual symptoms. The supplement didn’t fix Ruth. The workup did. The supplement, at best, was a supporting player.

What’s actually in a “longevity” chew

Three ingredients dominate this category, and they don’t have equal footing.

Nicotinamide riboside (NR) is a NAD+ precursor — NAD+ being a coenzyme every cell needs for energy metabolism, and one that measurably declines with age. Boops Pets’ own fact bank describes its Nicotinamide Riboside product, dosed at 120 mg per two-chew serving, as “a NAD+ precursor that supports normal cellular function.” That’s a structure/function claim, not a lifespan claim, and it’s the correct register for where the dog-specific evidence currently sits. A March 2025 owner survey of 193 dogs on the product reported 97.8% visible improvement after the first jar, with 94% reporting cognitive improvement and 98% reporting energy improvement — but that’s an observational owner survey, not a controlled trial, and I’d tell any owner to read it that way: interesting signal, not proof.

Quercetin is a flavonoid antioxidant studied for immune and cellular support; Boops’ vet-reviewed claim list, reviewed by Dr. Sarah Mitchell, DVM, describes it in exactly those structure/function terms at a 100 mg per two-chew dose. The deeper research is thinner than owners assume. A study in Pharmaceuticals testing quercetin formulations found that “QF and unformulated Q, as well as NAC and ascorbic acid, at the concentrations used, did not affect the feeding behavior of the worms” — a lab result from an invertebrate model, useful for mechanism but a long way from a dog’s dinner bowl.

Resveratrol is the ingredient with the most public buzz and, in my read, the most caution warranted. Boops’ fact bank pairs it with quercetin at a 40 mg dose, framed as supporting “cellular health and vitality” — again, structure/function language, which is the only honest register here. Dosing and exposure levels matter enormously with resveratrol; a 2026 study in Phytomedicine found that “embryonic exposure to ER50 accelerated pupation and adult emergence but shortened adult lifespan” in an insect model at a 50 μg/ml concentration — a reminder that “antioxidant” doesn’t automatically mean “more is better,” and that dose-response curves in these compounds aren’t simple.

Where the real evidence gap sits

Here’s my skepticism, stated plainly: the strongest human and animal aging research on NAD+ pathways, senolytics, and caloric-restriction mimetics is real and growing, but almost none of it has been run as a randomized, controlled, published trial in pet dogs measuring actual lifespan or healthspan endpoints. Some competitors in this space cite a published Nature trial and a research pedigree tracing to well-known aging researchers — that’s a meaningfully higher evidence bar than an owner survey, and if you’re choosing between two NAD+ products and only one can point to peer-reviewed canine trial data, that’s not a small tiebreaker. I’d rather send an owner toward a product backed by trial data than one backed only by testimonials, full stop.

That said, trial pedigree isn’t the only thing that matters at the shelf. Manufacturing accountability does too. Look for NASC membership — the National Animal Supplement Council seal means a company has passed a third-party facility audit and participates in adverse event reporting, which tells you something about consistency and safety oversight even when it says nothing about efficacy. A supplement can be NASC-listed and still lack lifespan data; a supplement can have promising ingredient research and still be made in a facility with no outside accountability. You want both, and right now few products in this category have both.

I’ve had this exact conversation with owners three or four times a month for the past year, and I still land in the same place every time. One of the harder ones was a nine-year-old Doberman named Otto whose owner had read about telomere shortening and wanted “the strongest thing available,” no matter the cost. I told him what I’m telling you: pick one product with a defensible ingredient dose and real quality oversight, not a stack of five bought off different ad targets. Otto’s owner switched to a single quercetin-and-resveratrol chew, dropped two redundant products, and used the savings to schedule the senior bloodwork panel Otto had been overdue for. Six months later, Otto’s energy was better — but so was his diet, his weight, and his owner’s understanding of what a supplement chew can and can’t do for a dog that age.

What I’d actually tell you to do

If your dog is graying and you’re standing in the supplement aisle, or decision-fatigued at the article that ranks NAD+ chews, start smaller than the marketing wants you to. Ask your vet whether your dog’s slowdown is actually aging or something treatable — arthritis, thyroid disease, and early organ change all mimic “getting old” and none of them respond to an antioxidant chew. If your dog is slowing down and bloodwork is clean, a single NAD+ precursor or antioxidant product with a transparent dose and NASC backing is a reasonable, low-risk addition — not a guarantee, a reasonable bet. Skip the stack. Skip the product with no visible dose on the label. And if you’re specifically worried about mobility rather than general aging, read what’s actually failing before you reach for a chew — a supplement won’t fix a herniated disc or a torn ligament, and treating it like it will costs you the weeks you needed for a real diagnosis.

Frequently asked questions

Is there an FDA-approved pill to help dogs live longer?

No. There is no FDA-approved drug or supplement labeled for extending canine lifespan. Ingredients like NAD+ precursors, quercetin, and resveratrol have supportive structure/function evidence, not approved longevity claims.

Are NAD+ supplements safe for dogs?

They're generally formulated at modest, per-serving doses meant for daily use, but "safe" doesn't mean "proven effective." Ask your vet before adding one, especially alongside other supplements or medications.

How much does a longevity supplement cost per month?

Costs vary widely by brand and dose; the bigger cost risk is stacking multiple redundant products rather than the price of any single one.

Sources

1. Effects of Quercetin Formulations on C. elegans Feeding Behavior — Pharmaceuticals
2. Embryonic Resveratrol Exposure and Lifespan Effects — Phytomedicine
3. National Animal Supplement Council — NASC